BREAKING! World Health Organisation report into estimated health effects from the Japanese Nuclear accident at Fukushima

The values presented in the report should be regarded as
inferences of the magnitude of the health risks, rather than as precise predictions.

“….Moreover, it is also important to note that the exposure data upon which this report is based are preliminary and include only data that were available as of September 2011.
Because scientific understanding of radiation effects, particularly at low doses, may increase in the future, it is possible that further investigation may change our understanding of the risks of this radiation accident……”

[Highlighted parts for your conenience. Also, there is nothing about the data on Thyroids as they stopped the data set in Sept 2011, before the results of the preliminary thyroid tests in early 2012?? So the estimated figures here are not very accurate? Why? – Arclight2011]

Thyroid cancer found from Fukushima children

Image source : http://fukushima-diary.com/2012/09/thyroid-cancer-found-from-fukushima-children/

SUMMARY.

Published on 28 Feb 2013

Health Risk Assessment from the nuclear accident after the
2011 Great East Japan Earthquake and Tsunami
based on a preliminary dose estimation
EXECUTIVE SUMMARY
Introduction
The earthquake and tsunami in Japan on 11 March 2011 led to releases of radioactive
material into the environment from the Tokyo Electric Power Company’s Fukushima
Daiichi nuclear power station.

A major release of radioactivity to the environment is always of concern, owing to
potential acute and long-term health effects. Evidence from historic events confirms that
any major uncontrolled release of radiation should be cause for immediate response
and scientific assessment of potential health effects.

When such an event occurs, the World Health Organization’s mandate, as described in
the Joint Radiation Emergency Management Plan of the International Organizations, is
to assess and respond to public health risks.

The primary purpose of this health risk assessment of the Fukushima Daiichi nuclear
accident is to estimate its potential public health impact so that future health needs can
be anticipated and public health actions can be taken. This assessment is based on a
preliminary estimate of radiation doses, as described in a WHO report published in May
2012.

Methods
This health risk assessment was conducted by independent international experts who
were selected by WHO for their expertise and experience in radiation risk modelling,
epidemiology, dosimetry, radiation effects and public health. All experts completed a
declaration of interests form. The group met in December 2011 and March 2012. At
both meetings, observers were in attendance from the United Nations Scientific
Committee on the Effects of Atomic Radiation (UNSCEAR), the International LabourOrganization, and the Government of Japan. The observers participated in discussions
and sharing of data but were not involved in the decision making process.

The risk assessment was made using four steps:
•
The specific radiation sources, such as different radionuclides and pathways
of exposure, were identified (hazard identification).
•
The types of harmful effects that could result were identified based on
scientific knowledge about the relationships between radiation dose and
biological effects (dose-response relationships).
•
Based on the preliminary dose assessment, lifetime organ doses were
estimated for the general population within geographical locations ranging
from the most affected areas of Fukushima prefecture to the rest of the world.

Based on available data on occupational exposure assessed by the operator
of the nuclear power station, lifetime organ doses were also estimated for
emergency workers (exposure assessment).
•
The lifetime risk of cancer was estimated for all solid cancers combined, and
also for individual cancer sites most closely associated with radiation
exposure and with a known dependence of the magnitude of risk on age-at-
exposure (leukaemia, thyroid cancer and female breast cancer). The lifetime
risks were estimated for both sexes and three different ages at exposure
(1 year [infant], 10 years [child], and 20 years [adult]). Calculations of the
cumulative risks for the 15 years following the accident were also performed.
Health risks for male emergency workers were estimated for three different
ages (20 years, 40 years, and 60 years) (risk characterization).

Findings
In view of the estimated exposure levels, an increased risk of cancer is the potential
health effect of greatest relevance. The relationship between radiation exposure and
lifetime risk of cancer is complex and varies depending on several factors, mainly
radiation dose, age at time of exposure, sex and cancer site. These factors can
influence the uncertainty in projecting radiation risks, in particular when assessing risks
at low doses.

Outside of the geographical areas most affected by radiation, even in locations within
Fukushima prefecture, the predicted risks remain low and no observable increases in
cancer above natural variation in baseline rates are anticipated.

Some health effects of radiation, termed deterministic effects, are known to occur only
after certain radiation dose levels are exceeded. The radiation doses in Fukushima
prefecture were well below such levels and therefore such effects are not expected to
occur in the general population.

The estimated dose levels in Fukushima prefecture were also too low to affect fetal
development or outcome of pregnancy and no increases, as a result of antenatal
2 radiation exposure, in spontaneous abortion, miscarriage, perinatal mortality, congenital
defects or cognitive impairment are anticipated.
In the two most affected locations of Fukushima prefecture, the preliminary estimated
radiation effective doses for the first year ranged from 12 to 25 mSv. In the highest dose
location, the estimated additional lifetime risks for the development of leukaemia, breast
cancer, thyroid cancer and all solid cancers over baseline rates are likely to represent
an upper bound of the risk as methodological options were consciously chosen to avoid
underestimation of risks. For leukaemia, the lifetime risks are predicted to increase by
up to around 7% over baseline cancer rates in males exposed as infants; for breast
cancer, the estimated lifetime risks increase by up to around 6% over baseline rates in
females exposed as infants; for all solid cancers, the estimated lifetime risks increase by
up to around 4% over baseline rates in females exposed as infants; and for thyroid
cancer, the estimated lifetime risk increases by up to around 70% over baseline rates in
females exposed as infants. These percentages represent estimated relative increases
over the baseline rates and are not absolute risks for developing such cancers. Due to
the low baseline rates of thyroid cancer, even a large relative increase represents a
small absolute increase in risks. For example, the baseline lifetime risk of thyroid cancer
for females is just three-quarters of one percent and the additional lifetime risk
estimated in this assessment for a female infant exposed in the most affected location is
one-half of one percent.

These estimated increases presented above apply only to the most affected location of
Fukushima prefecture. For the people in the second most affected location, the
estimated additional lifetime cancer risks over baseline rates are approximately one-half
of those in the highest dose location. The estimated risks are lower for people exposed
as children and adults compared to infants.

In the next most exposed group of locations in Fukushima prefecture, where preliminary
estimated radiation effective doses were 3 to 5 mSv, the increased lifetime estimates for
cancer risks over baseline rates were approximately one-quarter to one-third of those
for the people in the most affected geographical location.

Among Fukushima-Daiichi nuclear power station emergency workers, the lifetime risks
for leukaemia, thyroid cancer and all solid cancers are estimated to be increased over
baseline rates, based upon plausible radiation exposure scenarios. These scenarios
and their corresponding estimated risks are detailed in the body of this report. A few
emergency workers who inhaled significant quantities of radioactive iodine may develop
non-cancer thyroid disorders.

Conclusions
This health risk assessment is based on the current state of scientific knowledge. The
assessment models used were derived from previous radiation events and experience,
which do not match exactly the pattern of exposure seen in Fukushima; thus,
3 adjustments were required. The dose estimates and assumptions used in this
assessment were deliberately chosen to minimize the possibility of underestimating
eventual health risks. The values presented in the report should be regarded as
inferences of the magnitude of the health risks, rather than as precise predictions.

Moreover, it is also important to note that the exposure data upon which this report is
based are preliminary and include only data that were available as of September 2011.
Because scientific understanding of radiation effects, particularly at low doses, may
increase in the future, it is possible that further investigation may change our
understanding of the risks of this radiation accident.

This health risk assessment concludes that no discernible increase in health risks from
the Fukushima event is expected outside Japan. With respect to Japan, this
assessment estimates that the lifetime risk for some cancers may be somewhat
elevated above baseline rates in certain age and sex groups that were in the areas
most affected. These estimates provide valuable information for setting priorities in the
coming years for population health monitoring, as has already begun with the
Fukushima Health Management Survey.

On the basis of these findings, the continued monitoring of food and the environment
remains important. When additional dose estimations become available from studies
undertaken by UNSCEAR and others, such data can be used to further refine these risk
estimates.